info:eu-repo/grantAgreement/FCT/OE/SFRH%2FBPD%2F100434%2F2014/PTCharacterizing the clinical relevance of TRIB2 mediated resistance to PI3K pathway inhibition in colon and breast cancerSFRH/BPD/100434/2014